Turmeric References - Section iv

  1. Dairam, Amichaud. An Investigation into the Neuroprotective Properties of the Non-Steroidal Anti-Inflammatory Agents Tolmetin, Sulindac and Turmeric. Pharmacy. Grahamstown: Rhodes University. 2006. Thesis.
  2. Pharmacological and clinical properties of curcumin. Beevers, Christopher S. and Huang, Shile. [ed.] Ayse Kuruuzum-Uz. Ankara: Dove Medical Press Ltd., June 23, 2011, Botanics: Targets and Therapy, Vol. 1, pp. 5-18. DOI: 10.2147/BTAT.S17244; http://www.dovepress.com/pharmacological-and-clinical-properties-of-curcumin-peer-reviewed-article-BTAT. ISSN: 1179-9897.
  3. Neuroprotection by Spice-Derived Nutraceuticals: You Are What You Eat! Kannappan, Ramaswamy, et al., et al. [ed.] Nicolas G. Bazan. 2, New Orleans: Springer Science+Business Media, LLC, October 1, 2011, Molecular Neurobiology, Vol. 44, pp. 142-159. DOI: 10.1007/s12035-011-8168-2; http://link.springer.com/article/10.1007%2Fs12035-011-8168-2. ISSN: 0893-7648.
  4. Sarker, Satyajit D. and Nahar, Lutfun. Bioactivity of Turmeric. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 9, pp. 258-285. ISBN-13: 978-0-8493-7034-2.
  5. Sun, Albert Y., et al., et al. Botanical Phenolics and Neurodegeneration. [ed.] Iris F. F. Benzie and Sissi Wachtel-Galor. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd. Boca Raton: CRC Press: Taylor and Francis Group, LLC,2011, Vol. 28 of Oxidative Stress and Disease, 15, pp. 315-332. ISBN: 978-1-4398-0713-2.
  6. Aggarwal, Bharat B., Harikumar, Kuzhuvelil B. and Dey, Sanjit. Prevention and Treatment of Neurodegenerative Diseases by Spice-Derived Phytochemicals. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 20, pp. 281-308. ISBN: 978-1-4200-7351-5.
  7. Xu, Ying, Zhang, Chong and Ogle, William O. The Serotonergic System and Neuroplasticity are Implicated in the Effect of Phytochemicals on Mood and Cognitive Disorders. [ed.] Haixue Kuang. Recent Advances in Theories and Practice of Chinese Medicine. s.l.: InTech — Open Access Company, 2012, 15, pp. 291-312. ISBN: 978-953-307-903-5.
  8. Neuroprotective Effects Of Curcumin. Nabiuni, M., et al., et al. [ed.] Abdel Rahman Mohammad Said Al-Tawaha. 9, Amman: American-Eurasian Network for Scientific Information, September 2011, Australian Journal of Basic and Applied Sciences, Vol. 5, pp. 2224-2240. ISSN: 1991-8178.
  9. Ehrlich, Steven D. Dementia. University of Maryland Medical Center. [Online] May 7, 2013. [Cited: March 3, 2015.] http://www.umm.edu/altmed/articles/dementia-000046.htm.
  10. Epigenetic mechanisms in human physiology and diseases. Korkmaz, Ahmet, et al., et al. [ed.] Sukru Oter. 3, Ankara: Dr. Coskun Akay, June 1, 2011, Journal of Experimental and Integrative Medicine, Vol. 1, pp. 139-147. DOI: 10.5455/jeim.060611.rw.003; http://www.scopemed.org/?mno=5998. ISSN: 1309-4572.
  11. Cole, Greg M., Teter, Bruce and Frautschy, Sally A. Neuroprotective Effects of Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 197-212. ISBN-13: 978-0-387-46400-8.
  12. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Kuhad, Anurag and Chopra, Kanwaljit. [ed.] W.H. Gispen and F.P. Nijkamp. 1-3, Utrecht: Elsevier B.V., December 8, 2007, European Journal of Pharmacology, Vol. 576, pp. 34-42. DOI: 10.1016/j.ejphar.2007.08.001; http://www.sciencedirect.com/science/article/pii/S0014299907008916. ISSN: 0014-2999.
  13. Oxidative stress and hippocampus in a low-grade hepatic encephalopathy model: protective effects of curcumin. Roselló, Diego Martin, et al., et al. [ed.] Tetsuo Takehara. 11, Osaka: John Wiley & Sons, Inc.: The Japan Society of Hepatology, November 2008, Hepatology Research, Vol. 38, pp. 1148-1153. DOI: 10.1111/j.1872-034X.2008.00377.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1872-034X.2008.00377.x/abstract. eISSN: 1872-034X.
  14. Baugh, Nikkisha Antoinette. Effects of Curcumin on a C57BL/6J mouse model of thiamine deficiency induced Wernicke-Korsakoff Syndrome. Neuroscience. Wooster: The College of Wooster, 2012. Senior Independent Study Theses. Paper 65.
  15. Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein - a new mechanism for the inhibition of PrP(Sc) accumulation. Hafner-Bratkovič, Iva, et al., et al. [ed.] Jörg Schulz. 6, Aachen: John Wiley & Sons, Inc.: International Society for Neurochemistry, March 2008, Journal of Neurochemistry, Vol. 104, pp. 1553-1564. DOI: 10.1111/j.1471-4159.2007.05105.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2007.05105.x/abstract. eISSN: 1471-4159.
  16. Evaluation of drugs for treatment of prion infections of the central nervous system. Riemer, Constanze, et al., et al. [ed.] Richard M. Elliott. 2, St. Andrews: Society for General Microbiology, February 2008, Journal of General Virology, Vol. 89, pp. 594-597. DOI: 10.1099/vir.0.83281-0; http://vir.sgmjournals.org/content/89/2/594. ISSN: 0022-1317.
  17. GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice. Gilhotra, Neeraj and Dhingra, Dinesh. [ed.] Floyd E. Bloom. La Jolla: Elsevier B.V., September 17, 2010, Brain Research, Vol. 1352, pp. 167-175. DOI: 10.1016/j.brainres.2010.07.007; http://www.sciencedirect.com/science/article/pii/S0006899310015337. ISSN: 0006-8993.
  18. Possible nitric oxide modulation in protective effect of (Curcuma longa, Zingiberaceae) against sleep deprivation-induced behavioral alterations and oxidative damage in mice. Kumar, Anil and Singh, Anant. [ed.] Hildebert Wagner. 8, München: Elsevier GmbH: Urban and Fischer, August 1, 2008, Phytomedicine, Vol. 15, pp. 577-586. DOI: 10.1016/j.phymed.2008.02.003; http://www.sciencedirect.com/science/article/pii/S0944711308000196. ISSN: 0944-7113.
  19. Analgesic Effects of Intrathecal Curcumin in the Rat Formalin Test. Han, Yong Ku, et al., et al. [ed.] Kyung Hoon Kim. 1, Busan: The Korean Pain Society, January 2012, The Korean Journal of Pain, Vol. 25, pp. 1-6. DOI: 10.3344/kjp.2012.25.1.1; http://synapse.koreamed.org/DOIx.php?id=10.3344/kjp.2012.25.1.1. ISSN: 2005-9159.
  20. Brinker, Francis F. Enhancing Anti-Inflammatory Drug Effects with Botanicals. [ed.] David P. Rakel and Nancy Faass. Complementary Medicine in Clinical Practice: Integrative Practice In American Healthcare. Ontario: Jones and Bartlett Publishers, Inc., 2006, 61, pp. 445-458. ISBN-13: 978-0-7637-3065-9.
  21. Danette C. Taylor Pain Management: Neuropathic Pain. MedicineNet. [Online] December 11, 2013. [Cited: March 3, 2015.] http://www.medicinenet.com/neuropathic_pain_nerve_pain/article.htm.
  22. Dietary Curcumin Supplementation Counteracts Reduction in Levels of Molecules Involved in Energy Homeostasis after Brain Trauma. Sharma, S., et al., et al. [ed.] Stephen G. Lisberger. 4, Durham: Elsevier Ltd., July 21, 2009, Neuroscience, Vol. 161, pp. 1037-1044. DOI: 10.1016/j.neuroscience.2009.04.042; http://www.sciencedirect.com/science/article/pii/S0306452209006496. ISSN: 0306-4522.
  23. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Wilken, Reason, et al., et al. [ed.] Christophe Nicot and Alan Storey. 12, Kansas City; Oxford: Biomed Central Ltd., February 7, 2011, Molecular Cancer, Vol. 10, pp. 1-57. DOI: 10.1186/1476-4598-10-12; http://www.molecular-cancer.com/content/10/1/12#. ISSN: 1476-4598.
  24. Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model. Dohare, Preeti, et al., et al. [ed.] Thomas A. Rowles. 55, London: BioMed Central Ltd., September 30, 2008, BMC Complementary and Alternative Medicine, Vol. 8. DOI: 10.1186/1472-6882-8-55; http://www.biomedcentral.com/1472-6882/8/55. ISSN: 1472-6882.
  25. Anti-ischemic Effect of Curcumin in Rat Brain. Shukla, Pradeep K., et al., et al. [ed.] Abel Lajtha. 6, New York: Springer US, June 1, 2008, Neurochemical Research, Vol. 33, pp. 1036-1043. DOI: 10.1007/s11064-007-9547-y; http://link.springer.com/article/10.1007%2Fs11064-007-9547-y. ISSN: 0364-3190.
  26. The combined effects of exercise and foods in preventing neurological and cognitive disorders. Gomez-Pinilla, Fernando. [ed.] Alfredo Morabia. Supplement 1, New York: Elsevier Inc., June 1, 2011, Preventive Medicine, Vol. 52, pp. S75-S80. DOI: 10.1016/j.ypmed.2011.01.023; http://www.sciencedirect.com/science/article/pii/S009174351100051X. ISSN: 0091-7435.
  27. An Overview of Curcumin in Neurological Disorders. Kulkarni, S.K. and Dhir, A. [ed.] Rao V.S.V. Vadlamudi. 2, Vidyanagar: Wolters Kluwer Health: Medknow, Mar-Apr 2010, Indian Journal of Pharmaceutical Sciences, Vol. 72, pp. 149-154. DOI: 10.4103/0250-474X.65012; http://www.ijpsonline.com/article.asp?issn=0250-474X;year=2010;volume=72;issue=2;spage=149;epage=154;aulast=Kulkarni. ISSN: 0250-474X.
  28. Mood Disorders - Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior. Haroon, Ebrahim, Raison, Charles L. and Miller, Andrew H. [ed.] Peter Kalivas and Gwenn S. Smith. 1, s.l.: Nature Publishing Group: American College of Neuropsychopharmacology, January 2012, Neuropsychopharmacology Reviews, Vol. 37, pp. 137–162. DOI: 10.1038/npp.2011.205; http://www.nature.com/npp/journal/v37/n1/full/npp2011205a.html. ISSN: 0893-133X.
  29. Reactive astrocytes as therapeutic targets for CNS disorders. Hamby, Mary E. and Sofroniew, Michael V. [ed.] Alan I. Faden. 4, Baltimore: Elsevier, October 1, 2010, Neurotherapeutics, Vol. 7, pp. 494-506. DOI: 10.1016/j.nurt.2010.07.003; http://link.springer.com/article/10.1016%2Fj.nurt.2010.07.003. ISSN: 1933-7213.
  30. Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Blaylock, Russell L. and Maroon, Joseph. [ed.] James I. Ausman. 19, Los Angeles: Medknow, February 15, 2012, Surgical Neurology International®, Vol. 3. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307240/. ISSN: 2152-7806.
  31. Molecular mechanisms for anti-aging by natural dietary compounds. Pan, Min-Hsiung, et al., et al. [ed.] Hans-Ulrich Humpf. 1, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, January 2012, Molecular Nutrition & Food Research, Vol. 56, pp. 88-115. DOI: 10.1002/mnfr.201100509; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201100509/abstract. ISSN: 1613-4133.
  32. Freye, Enno. Representative Ailments with Excess Nitric Oxide Formation. Acquired Mitochondropathy - A New Paradigm in Western Medicine Explaining Chronic Diseases. Dordrecht: Springer Science+Business Media, 2012, 5, pp. 37-54. ISBN: 978-94-007-2035-0.
  33. Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model. Wang, Min S., et al., et al. [ed.] Melissa Norton. 57, St. Louis: BioMed Central Ltd., April 30, 2010, BMC Neuroscience, Vol. 11. DOI: 10.1186/1471-2202-11-57; http://www.biomedcentral.com/1471-2202/11/57. eISSN: 1471-2202.
  34. Balakrishnan, K.V. Postharvest Technology and Processing of Turmeric. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 8, pp. 193-256. ISBN-13: 978-0-8493-7034-2.
  35. Attokaran, Mathew. Turmeric: Curcuma longa L (Zingiberaceae). Natural Food Flavors and Colorants. Ames: Blackwell Publishing Ltd. and Institute of Food Technologists, 2011, 98, pp. 391-398. ISBN: 978-0-8138-2110-8.
  36. Khan, Nasiruddin, et al., et al. Resveratrol and Bioactive Flavonoids in Immune Function. [ed.] Ronald Ross Watson, Sherma Zibadi and Victor R. Preedy. Dietary Components and Immune Function. New York: Springer Science+Business Media, LLC, 2010, 23, pp. 397-420. ISBN: 978-1-60761-061-1; DOI: 10.1007/978-1-60761-061-8.
  37. Braun, Lesley and Cohen, Marc. Herbs & Natural Supplements: An Evidence-Based Guide. Marrickville: Elsevier Australia, 2007. ISBN-13: 978-0-7295-3796-4.
  38. Nahar, Lutfun and Sarker, Satyajit D. Phytochemistry of the Genus Curcuma. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 3, pp. 71-106. ISBN-13: 978-0-8493-7034-2.
  39. The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson's Disease. Mazzio, Elizabeth A., Close, Fran and Soliman, Karam F.A. [ed.] Andrei Alexandrescu. 1, Storrs: MDPI AG, January 17, 2011, International Journal of Molecular Sciences, Vol. 12, pp. 506-569. DOI: 10.3390/ijms12010506; http://www.mdpi.com/1422-0067/12/1/506. ISSN: 1422-0067.
  40. USDA Database for Standard Reference. NutriBase 7 Clinical Edition. s.l.: CyperSoft, 2007.
  41. Phytochemical flavonols, carotenoids and the antioxidant properties of a wide selection of Fijian fruit, vegetables and other readily available foods. Lako, Jimaima, et al., et al. [ed.] G.G. Birch. 4, Reading: Elsevier Ltd., 2007, Food Chemistry, Vol. 101, pp. 1727-1741. DOI: 10.1016/j.foodchem.2006.01.031; http://www.sciencedirect.com/science/article/pii/S0308814606000872. ISSN: 0308-8146.
  42. Fernstrom, J.D. and Fernstrom, M.H. Brain and Nervous System. [ed.] Benjamin Caballero, Lindsay Allen and Andrew Prentice. Encyclopedia of Human Nutrition. 2. Oxford: Elsevier, Ltd., 2005, Vol. I, pp. 225-232. ISBN: 0-12-150110-8.
  43. Metals, oxidative stress and neurodegenerative disorders. Jomova, Klaudia, et al., et al. [ed.] Naranjan S. Dhalla. 1-2, Winnipeg: Springer Science+Business Media, December 1, 2010, Molecular and Cellular Biochemistry, Vol. 345, pp. 91-104. DOI: 10.1007/s11010-010-0563-x; http://link.springer.com/article/10.1007%2Fs11010-010-0563-x. ISSN: 0300-8177.
  44. Chempakam, B. and Parthasarathy, V.A. Turmeric. [ed.] V.A. Parthasarathy, B. Chempakam and T. John Zachariah. Chemistry of Spices. Oxfordshire: CAB International, 2008, 6, pp. 97-123. ISBN: 978-1-84593-405-7.
  45. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease. Begum, Aynun N., et al., et al. [ed.] Rick G. Schnellmann. 1, Columbia: American Society for Pharmacology and Experimental Therapeutics, July 2008, Journal of Pharmacology and Experimental Therapeutics, Vol. 326, pp. 196-208. DOI: 10.1124/jpet.108.137455; http://jpet.aspetjournals.org/content/326/1/196. ISSN: 0022-3565.
  46. Calabrese, Vittorio, et al., et al. Phenolics in Aging and Neurodegenerative Disorders. [ed.] Cesar G. Fraga. Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology. Hoboken: John Wiley & Sons, Inc., 2010, 18, pp. 427-452. ISBN: 978-0-470-28721-7.
  47. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: A nutritional approach. Calabrese, V., et al., et al. [ed.] Gert Lubec. 3-4, Vienna: Springer-Verlag, December 1, 2003, Amino Acids, Vol. 25, pp. 437-444. DOI: 10.1007/s00726-003-0048-2; http://link.springer.com/article/10.1007%2Fs00726-003-0048-2. ISSN: 0939-4451.
  48. Strayer, David S. and Rubin, Emanuel. Cell Adaptation, Cell Injury and Cell Death. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 1, pp. 1-46. ISBN: 978-1-60547-968-2.
  49. Ramiro-Puig, Emma, et al., et al. Food Antioxidants and Alzheimer’s Disease. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 4, pp. 41-50. ISBN: 978-1-4200-7351-5.
  50. Curcumin Decreases Amyloid-β Peptide Levels by Attenuating the Maturation of Amyloid-β Precursor Protein. Zhang, Can, et al., et al. [ed.] Herbert Tabor. 37, Bethesda: American Society for Biochemistry and Molecular Biology, Inc., September 10, 2010, The Journal of Biological Chemistry, Vol. 285, pp. 28472-28480. DOI: 10.1074/jbc.M110.133520; http://www.jbc.org/content/285/37/28472. ISSN: 0021-972X.
  51. Hartman, Richard E. Actions of Bioactive Phytochemicals in Cell Function and Alzheimer’s Disease Pathology. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 16, pp. 225-242. ISBN: 978-1-4200-7351-5.
  52. Development of Tau Aggregation Inhibitors for Alzheimer's Disease. Bulic, Bruno, et al., et al. [ed.] Peter Gölitz. 10, Weinheim: Wiley-VCH Verlag GmbH & Co., February 2, 2009, Angewandte Chemie International Edition, Vol. 48, pp. 1740-1752. DOI: 10.1002/anie.200802621; http://onlinelibrary.wiley.com/doi/10.1002/anie.200802621/abstract. eISSN: 1521-3773.
  53. Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Kakkar, Vandita and Kaur, Indu Pal. [ed.] A. Wallace Hayes. 11, Andover: Elsevier Inc., November 2011, Food and Chemical Toxicology, Vol. 49, pp. 2906-2913. DOI: 10.1016/j.fct.2011.08.006; http://www.sciencedirect.com/science/article/pii/S0278691511004108. ISSN: 0278-6915.
  54. Maczurek, Annette E., et al., et al. Lipoic Acid as a Novel Treatment for Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease. [book auth.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 10, pp. 134-148. ISBN: 978-1-4200-7351-5.
  55. Bailey, Sarah J. and McCaffery, Peter J. Vulnerability of the Brain to Neuropsychiatric Disorders. [ed.] Michael S. Ritsner. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Dordrecht: Springer Science+Business Media B.V., 2010, 5, pp. 105-134. ISBN: 978-90-481-8552-8.
  56. Alzheimer's Scary Link To Diabetes. Rovner, Sophie L. 20, s.l.: American Chemical Society, May 18, 2009, Chemical & Engineering News, Vol. 87, pp. 42-46. ISSN: 0009-2347.
  57. Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease. de la Monte, Suzanne M. [ed.] Debomoy K. Lahiri. 1, Indianapolis: Bentham Science Publishers, January 2012, Current Alzheimer Research, Vol. 9, pp. 35-66. DOI: 10.2174/156720512799015037; http://www.eurekaselect.com/88685/article. ISSN: 1567-2050.
  58. Tortora, Gerard J. and Derrickson, Bryan. The Cellular Level of Organization. Principles of Anatomy & Physiology. Hoboken: John Wiley & Sons, Inc., 2012, 3, pp. 63-112. ISBN: 13 978-0470-56510-0.
  59. Immune blood biomarkers of Alzheimer disease patients. Avagyan, Hripsime, et al., et al. [ed.] Cedric S. Raine. 1-2, Bronx: Elsevier Inc., May 29, 2009, Journal of Neuroimmunology, Vol. 210, pp. 67-72. DOI: 10.1016/j.jneuroim.2009.02.015; http://www.jni-journal.com/article/S0165-5728(09)00067-8/abstract. ISSN: 0165-5728.
  60. Freye, Enno. Principles in Nitrosative Stress. Acquired Mitochondropathy - A New Paradigm in Western Medicine Explaining Chronic Diseases. Dordrecht: Springer Science+Business Media, 2012, 6, pp. 55-70. ISBN: 978-94-007-2035-0.
  61. Fuglestad, Anita J., Ramel, Sara E. and Georgieff, Michael K. Micronutrient Needs of the Developing Brain: Priorities and Assessment. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 8, pp. 93-116. ISBN: 978-1-4200-7351-5.
  62. Effect of antioxidants (vitamin C, E and turmeric extract) on methimazole induced hypothyroidism in rats. Deshpande, U.R., Joseph, L.J., Patwardhan, U.N., Samuel, A.M. [ed.] K.S. Krishnan Marg. 6, New Delhi: National Institute of Science Communication and Information Resources, June 2002, Indian Journal of Experimental Biology, Vol. 40, pp. 735-738. ISSN: 0019-5189.
  63. Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease. Ahmed, T., Enam, S.A., Gilani, A.H. [ed.] Stephen G. Lisberger. 3, Durham: Elsevier Ltd., September 1, 2010, Neuroscience, Vol. 169, pp. 1296-1306. DOI: 10.1016/j.neuroscience.2010.05.078; http://www.sciencedirect.com/science/article/pii/S0306452210008183. ISSN: 0306-4522.
  64. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Kidd, Parris M. [ed.] Kathleen A. Head. 2, Napa: Thorne Research, Inc., June 1, 2008, Alternative Medicine Review, Vol. 13. ISSN: 1089-5159.
  65. Duke, James A., Bogenschutz-Godwin, Mary Jo and duCellier, Judi. CRC Handbook of Medicinal Spices. Boca Raton: CRC Press LLC, 2003. ISBN: 0-8493-1279-5.
  66. Druggability of lead compounds from turmeric (Curcuma longa). Wilson, M., Balaji, S. and Eapen, S.J. 2006, Journal of Medicinal and Aromatic Plant Sciences, Vol. 28, pp. 384-390. ISSN: 0253-7125.
  67. Howes, Melanie-Jayne R. and Houghton, Peter J. Traditional Medicine for Memory Enhancement. [ed.] K.G. Ramawat. Herbal Drugs: Ethnomedicine to Modern Medicine. Berlin Heidelberg: Springer-Verlag, 2009, 15, pp. 239-292. ISBN: 978-3-540-79115-7.
  68. Foods for the prevention of diabetes: how do they work? Thomas, Theodoros and Pfeiffer, Andreas F.H. [ed.] Jesse Roth. 1, Manhasset: John Wiley & Sons, Ltd., January 3, 2012, Diabetes Metabolism Research and Reviews, Vol. 28, pp. 25-49. DOI: 10.1002/dmrr.1229; http://onlinelibrary.wiley.com/doi/10.1002/dmrr.1229/abstract. ISSN: 1520-7552.
  69. Marshall, Robert J. The Overlooked Role of Chronic Infection in Neurodegeneration and Its Reversal Using Nutraceutical Agents. Winter Park: Heise Health Clinic, 2005. pp. 1-23.
  70. Pressman, Alan H. and Buff, Sheila. The Complete Idiot's Guide to Vitamins and Minerals. New York: Alpha Books - Macmillan, Inc., 1997. ISBN: 0-02-862116-6.
  71. Strategies for Reducing or Preventing the Generation of Oxidative Stress. Poljsak, B. [ed.] Antonio Ayala. Article ID 194586, Sevilla: Hindawi Publishing Corporation, December 10, 2011, Oxidative Medicine and Cellular Longevity, Vol. 2011, pp. 1-15. DOI: 10.1155/2011/194586; http://www.hindawi.com/journals/omcl/2011/194586/. ISSN: 1942-0900.
  72. Molecular Targets of Dietary Polyphenols with Anti-inflammatory Properties. Yoon, Joo-Heon and Baek, Seung Joon. [ed.] Kwan Chul Tark. 5, Seoul: Yonsei University College of Medicine, October 31, 2005, Yonsei Medical Journal, Vol. 46, pp. 585-596. DOI: 10.3349/ymj.2005.46.5.585; http://synapse.koreamed.org/DOIx.php?id=10.3349/ymj.2005.46.5.585. ISSN: 0513-5796.
  73. Structural conversion of neurotoxic amyloid-β(1-42) oligomers to fibrils. Ahmed, Mahiuddin, et al., et al. [ed.] Boyana Konforti. 5, New York: Nature Publishing Group, May 2010, Nature Structural & Molecular Biology, Vol. 17, pp. 561-567. DOI: 10.1038/nsmb.1799; http://www.nature.com/nsmb/journal/v17/n5/full/nsmb.1799.html. ISSN: 1545-9993.
  74. Phenolic Compounds Prevent Alzheimer's Pathology through Different Effects on the Amyloid-β Aggregation Pathway. Hamaguchi, Tsuyoshi, F., et al., et al. [ed.] Michael P. Lisanti. 6, Philadelphia: American Society for Investigative Pathology, December 2009, The American Journal of Pathology, Vol. 175, pp. 2557-2565. DOI: 10.2353/ajpath.2009.090417; http://ajp.amjpathol.org/article/S0002-9440(10)60763-8/abstract. ISSN: 0002-9440.
  75. Impact of Dietary Polyphenols on Carbohydrate Metabolism. Hanhineva, Kati, et al., et al. [ed.] Andrei Alexandrescu. 4, Basel: MDPI AG, March 31, 2010, International Journal of Molecular Sciences, Vol. 11, pp. 1365-1402. DOI: 10.3390/ijms11041365; http://www.mdpi.com/1422-0067/11/4/1365. ISSN: 1422-0067.
  76. Jain, Kewal K. Neuroprotective Agents. The Handbook of Neuroprotection. Basel: Springer Science+Business Media, LLC, 2011, 2. ISBN: 978-1-161779-048-5.
  77. Alzheimer's Disease: The Pros and Cons of Pharmaceutical, Nutritional, Botanical, and Stimulatory Therapies, with a Discussion of Treatment Strategies from the Perspective of Patients and Practitioners. Wollen, Keith A. [ed.] Kathleen A. Head. 3, Napa: Thorne Research, Inc., September 2010, Alternative Medicine Review, Vol. 15, pp. 223-244. ISSN: 1089-5159.
  78. Amelioration of Obesity, Glucose Intolerance, and Oxidative Stress in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats by Combination Consisting of "Curcumin with Piperine and Quercetin". Kaur, Ginpreet and Chintamaneni, Meena. [ed.] T. Kumai and M.A. Prendergast. Article ID 957283, Mumbai: Hindawi Publishing Corporation, March 8, 2012, ISRN Pharmacology, Vol. 2012, pp. 1-7. DOI: 10.5402/2012/957283; http://www.hindawi.com/journals/isrn/2012/957283/. ISSN: 2090-5165.
  79. Effect of Polyphenols on Oxidative Stress and Mitochondrial Dysfunction in Neuronal Death and Brain Edema in Cerebral Ischemia. Panickar, Kiran S. and Anderson, Richard A. [ed.] Andrei Alexandrescu. 11, Basel: MDPI AG, November 18, 2011, International Journal of Molecular Sciences, Vol. 12, pp. 8181-8207. DOI: 10.3390/ijms12118181; http://www.mdpi.com/1422-0067/12/11/8181. ISSN: 1422-0067.
  80. The search for compounds that stimulate thermogenesis in obesity management: from pharmaceuticals to functional food ingredients. Dulloo, A.G., et al., et al. [ed.] David A. York. 10, Detroit: International Association for the Study of Obesity, October 2011, Obesity Reviews, Vol. 12, pp. 866-883. DOI: 10.1111/j.1467-789X.2011.00909.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1467-789X.2011.00909.x/abstract. eISSN: 1467-789X.
  81. Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects. Shytle, R. Douglas, et al., et al. [ed.] Debomoy K. Lahiri. 6, Indianapolis: Bentham Science Publishers, December 2009, Current Alzheimer Research, Vol. 6, pp. 564-571. DOI: 10.2174/156720509790147115; http://www.eurekaselect.com/85201/article. ISSN: 1567-2050.
  82. Cheng, Zhihong, Yu, Liangping and Yin, JunJie. Application of ESR in Wheat Antioidant Determination. [ed.] Liangli Yu. Wheat Antioxidants. Hoboken: Wiley-Interscience: John Wiley & Sons, Inc., 2008, 10, pp. 173-189. ISBN: 978-0-470-04259-5.
  83. Antioxidant and antiinflammatory activities of xanthorrhizol in hippocampal neurons and primary cultured microglia. Lim, Chol Seung, et al., et al. [ed.] Jean de Vellis. 6, Los Angeles: Wiley-Liss, Inc., December 15, 2005, Journal of Neuroscience Research, Vol. 82, pp. 831-838. DOI: 10.1002/jnr.20692; http://onlinelibrary.wiley.com/doi/10.1002/jnr.20692/abstract. ISSN: 0360-4012.
  84. Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats. Saraswat, Megha, et al., et al. [ed.] Jeffrey Boatright. a165, Atlanta: Emory University, August 10, 2010, Molecular Vision, Vol. 16, pp. 1525-1537. ISSN: 1090-0535.
  85. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease. Thomas, Philip, et al., et al. [ed.] P.J. Stambrook, L.H.F. Mullenders and L.R. Ferguson. 1-2, Cincinnati; Leiden; Auckland: Elsevier B.V., February 10, 2009, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 661, pp. 25-34. DOI: 10.1016/j.mrfmmm.2008.10.016; http://www.sciencedirect.com/science/article/pii/S0027510708002571. ISSN: 0027-5107.
  86. Hounsome, N. and Hounsome, B. Biochemistry of Vegetables: Major Classes of Primary (Carbohydrates, Amino Acids, Fatty Acids, Vitamins, and Organic Acids) and Secondary Metabolites (Terpenoids, Phenolics, Alkaloids, and Sulfur-Containing Compounds) in Vegetables. [ed.] Nirmal K. Sinha, et al., et al. Handbook of Vegetables and Vegetable Processing. Danvers: Wiley-Blackwell: Blackwell Publishing Ltd., 2011, 2, pp. 23-58. ISBN: 978-0-8138-1541-1.
  87. Mok, Su San and Bush, Ashley I. Therapeutics of Alzheimer’s Disease Based on Metal Bioavailability. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 9, pp. 117-132. ISBN: 978-1-4200-7351-5.
  88. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. Baum, Larry and Ng, Alex. [ed.] Mark A. Smith. 4, Cleveland: IOS Press, August 31, 2004, Journal of Alzheimer's Disease, Vol. 6, pp. 367-377. ISSN: 1387-2877.
  89. Aggarwal, Bharat B., et al., et al. Curcumin: The Indian Solid Gold. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 1-76. ISBN-13:978-0-387-46400-8.
  90. PPARγ and Agonists against Cancer: Rational Design of Complementation Treatments. Veliceasa, Dorina, Schulze-Hoëpfner, Frank Thilo and Volpert, Olga V. [ed.] Dipak Panigrahy. Article ID 945275, Boston: Hindawi Publishing Corporation, November 18, 2008, PPAR Research, Vol. 2008, pp. 1-13. DOI: 10.1155/2008/945275; http://www.hindawi.com/journals/ppar/2008/945275/. ISSN: 1687-4757.
  91. Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin. Ma, Qiu-Lan, et al., et al. [ed.] John Maunsell. 28, Chicago: Society for Neuroscience, July 15, 2009, The Journal of Neuroscience, Vol. 29, pp. 9078-9089. DOI: 10.1523/JNEUROSCI.1071-09.2009; http://www.jneurosci.org/content/29/28/9078. ISSN: 0270-6474.
  92. Champeau, Rachel. Vitamin D, curcumin may help clear amyloid plaques found in Alzheimer’s. University of California. [Online] July 15, 2009. [Cited: March 4, 2015.] http://newsroom.ucla.edu/portal/ucla/ucla-study-finds-vitamin-d-may-94903.aspx.
  93. Oral Curcumin for the Treatment of Mild-to-Moderate Alzheimer’s Disease: Tolerability and Clinical and Biomarker Efficacy Results of a Placebo-Controlled 24-week Study. Ringman, John M., et al., et al. Chicago: s.n., 2008. Proceedings of the Abstract of International Conference on Alzheimer’s Disease. p. T774. P4-344.
  94. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Koronyo-Hamaoui, Maya, et al., et al. [ed.] Paul Fletcher. 1, Cambridge: Elsevier Inc., January 2011, NeuroImage, Vol. 54, pp. S204–S217. DOI: 10.1016/j.neuroimage.2010.06.020; http://www.sciencedirect.com/science/article/pii/S1053811910008645. ISSN: 1053-8119.
  95. Curcumin and Alzheimer's Disease. Hamaguchi, Tsuyoshi, Ono, Kenjiro and Yamada, Masahito. [ed.] Ding-Feng Su. 5, Shanghai: Blackwell Publishing Ltd, October 2010, CNS Neuroscience & Therapeutics, Vol. 16, pp. 285-297. DOI: 10.1111/j.1755-5949.2010.00147.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00147.x/abstract. eISSN: 1755-5949.
  96. Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease. Baum, Larry, et al., et al. [ed.] Richard I. Shader and David J. Greenblatt. 1, Medford: Lippincott Williams & Wilkins, Inc., February 2008, Journal of Clinical Psychopharmacology, Vol. 28, pp. 110-113. DOI: 10.1097/jcp.0b013e318160862c; http://journals.lww.com/psychopharmacology/Citation/2008/02000/Six_Month_Randomized,_Placebo_Controlled,.25.aspx. ISSN: 0271-0749.
  97. Schor, Jacob. Alzheimer’s Disease and Curcumin: a Protocol Update. Denver Naturopathic Clinic. [Online] June 15, 2010. [Cited: July 31, 2015.] http://www.denvernaturopathic.com/Alzheimers2010update.htm.
  98. Injectable Sustained Release Microparticles of Curcumin: A New Concept for Cancer Chemoprevention. Shahani, Komal, et al., et al. [ed.] George C. Prendergast. 11, Wynnewood: American Association for Cancer Research, June 1, 2010, Cancer Research, Vol. 70, pp. 4443-4452. DOI: 10.1158/0008-5472.CAN-09-4362; http://cancerres.aacrjournals.org/content/70/11/4443. ISSN: 0008-5472.
  99. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Makadia, Hirenkumar K. and Siegel, Steven J. [ed.] Alexander Böker. 3, Potsdam: MDPI AG, August 8, 2011, Polymers, Vol. 3, pp. 1377-1397. DOI: 10.3390/polym3031377; http://www.mdpi.com/2073-4360/3/3/1377. eISSN: 2073-4360.
  100. The Michael J. Fox Foundation for Parkinson’s Research. Understanding Parkinson's. The Michael J. Fox Foundation for Parkinson's Research. [Online] [Cited: March 5, 2015.] https://www.michaeljfox.org/understanding-parkinsons/index.html.
  101. Freye, Enno. Nitrosative Stress in Diverse Multisystem Diseases. Acquired Mitochondropathy - A New Paradigm in Western Medicine Explaining Chronic Diseases. Dordrecht: Springer Science+Business Media, 2012, 7, pp. 71-216. ISBN: 978-94-007-2035-0.
  102. Tortora, Gerard J. and Derrickson, Bryan. Nervous Tissue. Principles of Anatomy & Physiology. Hoboken: John Wiley & Sons, Inc., 2012, 12, pp. 447-491. ISBN: 13 978-0470-56510-0.
  103. Mitochondrial Fusion/Fission, Transport and Autophagy in Parkinson's Disease: When Mitochondria Get Nasty. Arduíno, Daniela M., Esteves, A. Raquel and Cardoso, Sandra M. [ed.] Charleen T. Chu. Article ID 767230, Pittsburgh: Hindawi Publishing Corporation, February 20, 2011, Parkinson's Disease, Vol. 2011, pp. 1-13. DOI: 10.4061/2011/767230; http://www.hindawi.com/journals/pd/2011/767230/. ISSN: 2090-8083.
  104. University of British Columbia. Severe Flu Increases Risk of Parkinson's. ScienceDaily. [Online] July 20, 2012. [Cited: March 5, 2015.] http://www.sciencedaily.com/releases/2012/07/120720135717.htm.
  105. Curcumin inhibits influenza virus infection and haemagglutination activity. Chen, Da-Yuan, et al., et al. [ed.] G.G. Birch. 4, Reading: Elsevier B.V., April 15, 2010, Food Chemistry, Vol. 119, pp. 1346-1351. DOI: 10.1016/j.foodchem.2009.09.011; http://www.sciencedirect.com/science/article/pii/S0308814609010553. ISSN: 0308-8146.
  106. Curcuminoids from Curcuma longa and their inhibitory activities on influenza A neuraminidases. Dao, Trong Tuan, et al., et al. [ed.] G.G. Birch. 1, Reading: Elsevier Ltd., September 1, 2012, Food Chemistry, Vol. 134, pp. 21-28. DOI: 10.1016/j.foodchem.2012.02.015; http://www.sciencedirect.com/science/article/pii/S030881461200180X. ISSN: 0308-8146.
  107. The Medicinal Potential of Influenza Virus Surface Proteins: Hemagglutinin and Neuraminidase. Xie, Y., et al., et al. [ed.] Atta-ur-Rahman. 7, Karachi: Bentham Science Publishers, March 1, 2011, Current Medicinal Chemistry, Vol. 18. DOI: 10.2174/092986711794940815; http://www.eurekaselect.com/73473/article. ISSN: 1875-533X.
  108. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Rajeswari, A. and Sabesan, M. [ed.] K.D. Rainsford. 2, Sheffield: SP Birkhäuser Verlag Basel, April 1, 2008, Inflammopharmacology, Vol. 16, pp. 96-99. DOI: 10.1007/s10787-007-1614-0; http://link.springer.com/article/10.1007%2Fs10787-007-1614-0. ISSN: 0925-4692.
  109. Buchbauer, Gerhard. Biological Activities of Essential Oils. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 9, pp. 235-280. ISBN: 978-1-4200-6315-8.
  110. Heuberger, Eva. Central Nervous System Effects of Essential Oils in Humans. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 10.1, pp. 281-296. ISBN: 978-1-4200-6315-8.
  111. Gerstein, Paul S. Delirium, Dementia, and Amnesia in Emergency Medicine. Medscape Reference: Drugs, Diseases & Procedures. [Online] April 4, 2013. [Cited: March 5, 2015.] http://emedicine.medscape.com/article/793247-overview#showall.
  112. Davis, Charles Patrick. Encephalopathy: What is encephalopathy?; What causes encephalopathy? MedicineNet. [Online] June 9, 2014. [Cited: March 5, 2015.] http://www.medicinenet.com/encephalopathy/article.htme.
  113. Dementia syndromes: evaluation and treatment. Scott, Kevin R. and Barrett, Anna M. [ed.] Laura McGovern. 4, London: Informa Plc, April 2007, Expert Review of Neurotherapeutics, Vol. 7, pp. 407-422. DOI: 10.1586/14737175.7.4.407; http://informahealthcare.com/doi/abs/10.1586/14737175.7.4.407. ISSN: 1473-7175.
  114. Marcovitch, Harvey. Black's Medical Dictionary. 41. London: A & C Black Publishers Limited, 2005. ISBN: 0-7136-6146-1.
  115. Fuller, Gregory N., Goodman, J. Clay and Bouldin, Thomas W. The Nervous System. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 28, pp. 1295-1392. ISBN: 978-1-60547-968-2.
  116. Fry, Mitchell. Nerve and muscle systems. Essential Biochemistry for Medicine. Chichester: Wiley-Blackwell: John Wiley & Sons Ltd., 2010, 17, pp. 237-254. ISBN: 978-0-470-74328-7.
  117. Newsholme, Eric A. and Leech, Tony R. Defence Against Pathogens: Barriers, Enzymes and the Immune System. Functional Biochemistry in Health and Disease. Chichester: Wiley-Blackwell: John Wiley & Sons, Ltd, 2010, 17, pp. 375-416. ISBN: 978-0-471-98820-5.
  118. Bovine spongiform encephalopathy and Creutzfeldt-Jacob's disease - 15 years later, where do we stand? Chatzidaki, E.E. [ed.] John Meletis. 3, Athens: Athens Medical Society, June 2010, Archives of Hellenic Medicine, Vol. 27, pp. 471-474. ISSN: 1105-3992.
  119. Hepatic encephalopathy: An approach to its multiple pathophysiological features. Perazzo, Juan Carlos, et al., et al. [ed.] Masatoshi Kudo. 3, Osaka: Baishideng Publishing Group Co., Limited, March 27, 2012, World Journal of Hepatology, Vol. 4, pp. 50-65. DOI: 10.4254/wjh.v4.i3.50; http://www.wjgnet.com/1948-5182/full/v4/i3/50.htm. ISSN: 1948-5182.
  120. Prasad, Sahdeo and Aggarwal, Bharat B. Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine. [ed.] Iris F.F. Benzie and Sissi Wachtel-Galor. Herbal Medicine: Biomolecular and Clinical Aspects. 2. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2011, 13, pp. 263-288. ISBN: 978-1-4398-0713-2.
  121. Kumar, Addanki P., et al., et al. An Overview of Anticancer Herbal Medicines. [ed.] William C.S. Cho. Evidence-Based Anticancer Materia Medica. Dordrecht: Springer Science+Business Media B.V., 2011, 1, pp. 1-36. ISBN: 978-94-007-0525-8.
  122. NINDS Office of Communications and Public Liaison. Acute Disseminated Encephalomyelitis Information Page. National Institute of Neurological Disorders and Stroke. [Online] February 14, 2014. [Cited: March 5, 2015.] http://www.ninds.nih.gov/disorders/acute_encephalomyelitis/acute_encephalomyelitis.htm.
  123. The Cleveland Clinic Foundation. Diseases & Conditions: Acute Disseminated Encephalomyelitis (ADEM). The Cleveland Clinic. [Online] August 22, 2014. [Cited: March 5, 2015.] http://my.clevelandclinic.org/disorders/acute_disseminated_encephalomyelitis_adem/hic_overview.aspx.
  124. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Kulkarni, Shrinivas K., Bhutani, Mohit Kumar and Bishnoi, Mahendra. [ed.] T.W. Robbins, et al., et al. 3, Cambridge; Medford; London; Melbourne; Chicago; London; Providence; Beerse; Philadelphia; Chapel Hill: Springer-Verlag, December 1, 2008, Psychopharmacology , Vol. 201, pp. 435-442. DOI: 10.1007/s00213-008-1300-y; http://link.springer.com/article/10.1007%2Fs00213-008-1300-y. ISSN: 0033-3158.
  125. Milbury, Paul E. Transport of Flavonoids into the Brain. [ed.] Lester Packer, et al., et al. Micronutrients and Brain Health. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 19, pp. 265-280. ISBN: 978-1-4200-7351-5.
  126. Nunes, Domingos Sávio, et al., et al. Effects of Essential Oils in the Central Nervous System: Psychopharmacology of Essential Oils. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 10.2, pp. 297-306. ISBN: 978-1-4200-6315-8.
  127. Lis-Balchin, Maria. Aromatherapy with Essential Oils. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 11, pp. 549-584. ISBN: 978-1-4200-6315-8.
  128. Krzyzanowska, Justyna, Czubacka, Anna and Oleszek, Wieslaw. Dietary Phytochemicals and Human Health. [ed.] Maria Teresa Giardi, Giuseppina Rea and Bruno Berra. Bio-Farms for Nutraceuticals: Functional Food and Safety Control by Biosensors. Austin: Landes Bioscience and Springer Science+Business Media, LLC, 2010, 7, pp. 74-98. ISBN: 978-1-4419-7346-7.
  129. The Role of Dietary Polyphenols on Adult Hippocampal Neurogenesis: Molecular Mechanisms and Behavioural Effects on Depression and Anxiety. Dias, Gisele Pereira, et al., et al. Article ID 541971, Modena: Hindawi Publishing Corporation, April 17, 2012, Oxidative Medicine and Cellular Longevity, Vol. 2012, pp. 1-18. DOI: 10.1155/2012/541971; http://www.hindawi.com/journals/omcl/2012/541971/. ISSN: 1942-0900.
  130. Bouayed, Jaouad. Relationship Between Oxidative Stress and Anxiety: Emerging Role of Antioxidants Within Therapeutic or Preventive Approaches. [ed.] Vladimir V. Kalinin. Anxiety Disorders. Rijeka: InTech, 2011, 2, pp. 27-38. ISBN: 978-953-307-592-1.
  131. The molecular basis of neurodegeneration in multiple sclerosis. Lassmann, Hans and van Horssen, Jack. [ed.] Felix Wieland. 23, Heidelberg: Elsevier B.V., December 1, 2011, FEBS Letters, Vol. 585, pp. 3715-3723. DOI: 10.1016/j.febslet.2011.08.004; http://www.febsletters.org/article/S0014-5793(11)00593-X/abstract. ISSN: 0014-5793.
  132. Shah, Jyoti. Herbal Treatments for Erectile Dysfunction. [ed.] K.G. Ramawat. Herbal Drugs: Ethnomedicine to Modern Medicine. Berlin Heidelberg: Springer-Verlag, 2009, 5, pp. 67-80. ISBN: 978-3-540-79115-7.
  133. May Diet and Dietary Supplements Improve the Wellness of Multiple Sclerosis Patients? A Molecular Approach. Riccio, Paolo, Rossano, Rocco and Liuzzi, GraziaMaria. [ed.] Corrado Betterle. Article ID 249842, Padua: SAGE-Hindawi Access to Research, December 27, 2010, Autoimmune Diseases, Vol. 2010, pp. 1-12. DOI: 10.4061/2010/249842; http://www.hindawi.com/journals/ad/2010/249842/. ISSN: 2090-0430.
  134. Bright, John J. Curcumin and Autoimmune Disease. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Aggarwal, Bharat B.; Surh, Young-Joon; Shishodia, Shishir, 2007, pp. 425-452. ISBN-13:978-0-387-46400-8.
  135. Curcumin has bright prospects for the treatment of multiplesclerosis. Xiea, Lin, Li, Xiao-Kang and Takahara, Shiro. [ed.] J.E. Talmadge. 3, Omaha: Elsevier B.V., March 2011, International Immunopharmacology, Vol. 11, pp. 323-330. DOI: 10.1016/j.intimp.2010.08.013; http://www.sciencedirect.com/science/article/pii/S1567576910002675. ISSN: 1567-5769.
  136. Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Verbeek, Richard, van Tol, Eric. A.F. and van Noort, Johannes M. [ed.] Sam J. Enna. 2, Kansas City: Elsevier B.V., July 15, 2005, Biochemical Pharmacology, Vol. 70, pp. 220-228. DOI: 10.1016/j.bcp.2005.04.041; http://www.sciencedirect.com/science/article/pii/S0006295205002340. ISSN: 0006-2952.
  137. Aggarwal, Bharat B., et al., et al. Curcumin Derived from Turmeric (Curcuma longa): a Spice for All Seasons. [ed.] Debasis Bagchi and Harry G. Preuss. Phytopharmaceuticals in Cancer Chemoprevention. Boca Raton: CRC Press LLC, 2005, 23, pp. 349-388. ISBN: 0-8493-1560-3.
  138. Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-β. Sternberg, Zohara, et al., et al. [ed.] Sue T. Griffin and Robert E. Mrak. 28, Little Rock; Toledo: BioMed Central Ltd., October 13, 2009, Journal of Neuroinflammation, Vol. 6. DOI: 10.1186/1742-2094-6-28; http://www.jneuroinflammation.com/content/6/1/28. eISSN: 1742-2094.
  139. Differential regulation of CD4+ T helper cell responses by curcumin in experimental autoimmune encephalomyelitis. Kanakasabai, Saravanan, et al., et al. [ed.] Edward A. Dennis and Joseph L. Witztum. 11, San Diego: American Society for Biochemistry and Molecular Biology, March 6, 2012, The Journal of Nutritional Biochemistry, Vol. 23, pp. 1498-1507. DOI: 10.1016/j.jnutbio.2011.10.002; http://www.jnutbio.com/article/S0955-2863(11)00288-9/abstract. ISSN: 0022-2275.
  140. Miriyala, Sumitra, Panchatcharam, Manikandan and Rengarajulu, Puvanakrishnan. Cardioprotective Effects of Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 359-378. ISBN-13:978-0-387-46400-8.
  141. Wilberger, James E. and Dupre, Derrick A. Intracranial Hematomas. Merck Sharp & Dohme Corp. [Online] November 2013. [Cited: March 6, 2015.] http://www.merckmanuals.com/home/injuries_and_poisoning/head_injuries/intracranial_hematomas.html.
  142. Curcumin (Diferuloylmethane) Induces Apoptosis and Blocks Migration of Human Medulloblastoma Cells. Bangaru, Madhavi Latha Yadav, et al., et al. [ed.] Gen-Ichiro Soma. 2, Takamatsu: The International Institute of Anticancer Research, February 2010, Anticancer Research, Vol. 30, pp. 499-504. ISSN: 0250-7005.
  143. Epigenetic changes induced by curcumin and other natural compounds. Reuter, Simone, et al., et al. [ed.] Giuditta Perozzi, et al., et al. 2, Rome; Lausanne; Utrecht: Springer-Verlag, May 1, 2011, Genes & Nutrition, Vol. 6, pp. 93-108. DOI: 10.1007/s12263-011-0222-1; http://link.springer.com/article/10.1007%2Fs12263-011-0222-1. ISSN: 1555-8932.
  144. Caldecott, Todd. Ayurveda: The Divine Science of Life. s.l.: Elsevier Health Sciences, 2006. ISBN: 978-0-7234-3410-8.
  145. Barnes, Joanne, Anderson, Linda A. and Phillipson, J. David. Herbal Medicines. 3. London: Pharmaceutical Press: RPS Publishing, 2007. ISBN: 978-0-85369-623-0.
  146. Committee on Herbal Medicinal Products. Assessment Report on Curcuma Longa L. Rhizoma. London: European Medicines Agency, 2009. EMEA/HMPC/456848/2008.
  147. Hsu, Chih-Hung and Cheng, Ann-Lii. Clinical Studies with Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 471-480. ISBN-13: 978-0-387-46400-8.
  148. High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy. Purwata, Thomas Eko. [ed.] Howard S. Smith. Albany: Dove Medical Press, June 29, 2011, Journal of Pain Research, Vol. 4, pp. 169-175. DOI: 10.2147/JPR.S21751; http://www.dovepress.com/high-tnf-alpha-plasma-levels-and-macrophages-inos-and-tnf-alpha-expres-peer-reviewed-article-JPR. ISSN: 1178-7090.
  149. Phase II Clinical Trial on Effect of the Long Turmeric (Curcuma Longa Linn) on Healing of Peptic Ulcer. Prucksunand, Chaweewan, et al., et al.  [ed.] Suvanee Supavej. 1, Bangkok: SEAMEO Regional Tropical Medicine and Public Health Network, March 2001, The Southeast Asian Journal of Tropical Medicine and Public Health, Vol. 32, pp. 208-215. ISSN: 0125-1562.
  150. Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study. Agarwal, Krishna Adit, et al., et al. [ed.] Mark A. Talamini and Sir Alfred Cuschieri. 12, Stony Brook; Dundee: Springer-Verlag, December 1, 2011, Surgical Endoscopy, Vol. 25, pp. 3805-3810. DOI: 10.1007/s00464-011-1793-z; http://link.springer.com/article/10.1007%2Fs00464-011-1793-z. ISSN: 0930-2794.
  151. Early Human Safety Study of Turmeric Oil (Curcuma longa oil) administered orally in healthy volunteers. Joshi, Jayashree, et al., et al. [ed.] Shashank R. Joshi. Mumbai: Association of Physicians of India, November 2003, Journal of The Association of Physicians of India, Vol. 51, pp. 1055-1060. ISSN: 0004-5772.
  152. Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Mittal, Nitt, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 4, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., April 2009, Phytotherapy Research, Vol. 23, pp. 507-512. DOI: 10.1002/ptr.2662; http://onlinelibrary.wiley.com/doi/10.1002/ptr.2662/abstract. eISSN: 1099-1573.
  153. Gautam, Subhash C., Gao, Xiaohua and Dulchavsky, Scott. Immunomodulation by Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 321-342. ISBN-13:978-0-387-46400-8.
  154. Origins of Plant Derived Medicines. Maridass, M. and Britto, A. John De. 12, Palayamkottai: s.n., June 11, 2008, Ethnobotanical Leaflets, pp. 373-387. ISSN: 1948-3570.
  155. Molecular Targets of Nutraceuticals Derived from Dietary Spices: Potential Role in Suppression of Inflammation and Tumorigenesis. Aggarwal, Bharat B., et al., et al. [ed.] Steven R. Goodman. 8, Syracuse: SAGE: The Society for Experimental Biology and Medicine, August 2009, Experimental Biology and Medicine, Vol. 234, pp. 825-849. DOI: 10.3181/0902-MR-78; http://ebm.sagepub.com/content/234/8/825. ISSN: 1535-3699.
  156. Harris, Bob. Phytotherapeutic Uses of Essential Oils. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 11, pp. 315-353. ISBN: 978-1-4200-6315-8.
  157. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Zhong, Zhangfeng, et al., et al. [ed.] FP. Nijkamp. 1-3, Utrecht: Elsevier B.V., September 30, 2011, European Journal of Pharmacology, Vol. 667, pp. 50-55. DOI: 10.1016/j.ejphar.2011.03.041; http://www.sciencedirect.com/science/article/pii/S0014299911003578. ISSN: 0014-2999.
  158. Khan, Ikhlas A. and Abourashed, Ehab A. Leung's Encyclopedia of Common Natural Ingredients: Used in Food, Drugs and Cosmetics. 3. Hoboken: John Wiley & Sons, Inc., 2010. ISBN: 978-0-471-46743-4.
  159. Nunes, Domingos Sávio, et al., et al. Effects of Essential Oils in the Central Nervous System: Central Nervous System Effects of Essential Oils in Humans. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 10.1, pp. 281-296. ISBN: 978-1-4200-6315-8.
  160. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Durgaprasad, S., et al., et al. [ed.] V.M. Katoch. 4, New Delhi: Indian Council of Medical Research, October 2005, Indian Journal of Medical Research, Vol. 122, pp. 315-318. ISSN: 0971-5916.
  161. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Reeta, K.H., et al., et al. [ed.] George F. Koob. 3, La Jolla: Elsevier Inc., September 2011, Pharmacology Biochemistry and Behavior, Vol. 99, pp. 399-407. DOI: 10.1016/j.pbb.2011.05.011; http://www.sciencedirect.com/science/article/pii/S0091305711001535. ISSN: 0091-3057.
  162. Pictorial Review of Glutamate Excitotoxicity: Fundamental Concepts for Neuroimaging. Mark, Leighton P., et al., et al. [ed.] Robert M. Quencer. 3, Miami: American Society of Neuroradiology, Nov-Dec 2001, American Journal of Neuroradiology, Vol. 22, pp. 1813-1824. ISSN: 1936-959X.
  163. Biological Sciences Curriculum Study. The Brain: Understanding Neurobiology Through the Study of Addiction - Neurons, Brain Chemistry, and Neurotransmission. Colorado Springs: U.S. Department of Health and Human Services: National Institutes of Health, 2010. pp. 41-64. NIH Publication No. 09-4871 ISBN: 1-929614-05-5.
  164. Frontier of Epilepsy Research - mTOR signaling pathway. Dae-Myung Jue. 5, Seoul: Nature Publishing Group; Korean Society for Biochemistry and Molecular Biology , May 31, 2011, Experimental & Molecular Medicine, Vol. 43, pp. 231-274. DOI: 10.3858/emm.2011.43.5.032; http://www.nature.com/emm/journal/v43/n5/full/emm201128a.html. eISSN: 2092-6413.
  165. Shpakov, Alexander, et al., et al. Hormonal Signaling Systems of the Brain in Diabetes Mellitus. [ed.] Raymond Chuen-Chung Chang. Neurodegenerative Diseases - Processes, Prevention, Protection and Monitoring. s.l.: InTech, 2011, 15, pp. 349-386. ISBN: 978-953-307-485-6.
  166. Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Noor, Neveen A., et al., et al. [ed.] Steven C. Schachter. 2, Boston: Elsevier Inc., June 2012, Epilepsy & Behavior, Vol. 24, pp. 199-206. DOI: 10.1016/j.yebeh.2012.03.026; http://www.epilepsybehavior.com/article/S1525-5050(12)00171-0/abstract. ISSN: 1525-5050.
  167. Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Noor, Neveen A., et al., et al. [ed.] Steven C. Schachter. 2, Boston: Elsevier Inc., June 2012, Epilepsy & Behavior, Vol. 24, pp. 199-206. DOI: 10.1016/j.yebeh.2012.03.026; http://www.epilepsybehavior.com/article/S1525-5050(12)00171-0/abstract. ISSN: 1525-5050.
  168. Natural Antioxidants May Prevent Posttraumatic Epilepsy: A Proposal Based on Experimental Animal Studies. Mori, Akitane, et al., et al. [ed.] Masao Yamada. 3, Okayama: Okayama University Medical School, June 2004, Acta Medica Okayama, Vol. 58, pp. 111-118. ISSN: 0386-300X.
  169. Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model. Mehla, Jogender, et al., et al. [ed.] Frank Porreca. 19-22, Tucson: Elsevier Inc., November 20, 2010, Life Sciences, Vol. 87, pp. 596-603. DOI: 10.1016/j.lfs.2010.09.006; http://www.sciencedirect.com/science/article/pii/S0024320510003814. ISSN: 0024-3205.
  170. Dietary Curcumin Attenuates Glioma Growth in a Syngeneic Mouse Model by Inhibition of the JAK1,2/STAT3 Signaling Pathway. Weissenberger, Jakob, et al., et al. [ed.] Kenneth C. Anderson. 23, Philadelphia: American Association for Cancer Research, December 1, 2010, Clinical Cancer Research, Vol. 16, pp. 5781-5795. DOI: 10.1158/1078-0432.CCR-10-0446; http://clincancerres.aacrjournals.org/content/16/23/5781. ISSN: 1557-3265.
  171. Essential Oils and Their Constituents: Anticonvulsant Activity. de Almeida, Reinaldo Nóbrega, et al., et al. [ed.] Derek J. McPhee. 3, Emeryville: MDPI AG, March 23, 2011, Molecules, Vol. 16, pp. 2726-2742. DOI: 10.3390/molecules16032726; http://www.mdpi.com/1420-3049/16/3/2726. ISSN: 1420-3049.
  172. Anticonvulsant activity of bisabolene sesquiterpenoids of Curcuma longa in zebrafish and mouse seizure models. Orellana-Paucar, Adriana Monserrath, et al., et al. [ed.] Steven C. Schachter. 1, Boston: Elsevier Inc., May 2012, Epilepsy & Behavior, Vol. 24, pp. 14-22. DOI: 10.1016/j.yebeh.2012.02.020; http://www.epilepsybehavior.com/article/S1525-5050(12)00086-8/abstract. ISSN: 1525-5050.
  173. GABA receptor agonists: pharmacological spectrum and therapeutic actions. Bartholini, G. 1, s.l.: Wiley Periodicals, Inc., January/March 1985, Medicinal Research Reviews, Vol. 5, pp. 55-75. DOI: 10.1002/med.2610050103; http://onlinelibrary.wiley.com/doi/10.1002/med.2610050103/abstract. eISSN: 1098-1128.
  174. Effect of eugenol on spreading depression and epileptiform discharges in rat neocortical and hippocampal tissues. orm discharges in rat neocortical and hippocampal tissues. Müller, M., et al., et al. [ed.] Stephen G. Lisberger. 2, Durham: Elsevier Ltd., June 30, 2006, Neuroscience, Vol. 140, pp. 743-751. DOI: 10.1016/j.neuroscience.2006.02.036; http://www.sciencedirect.com/science/article/pii/S0306452206002399. ISSN: 0306-4522.
  175. Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study. Bergman, Joseph, et al., et al. [ed.] Peter A. LeWitt. 3, West Bloomfield: Wolters Kluwer Health, Inc., May/June 2013, Clinical Neuropharmacology, Vol. 36, pp. 73-77. DOI: 10.1097/WNF.0b013e31828ef969; http://journals.lww.com/clinicalneuropharm/pages/articleviewer.aspx?year=2013&issue=05000&article=00001&type=abstract. ISSN: 0362-5664.
  176. Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial. Sanmukhani, Jayesh, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 4, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., April 2014, Phytotherapy Research, Vol. 28, pp. 579-585. DOI: 10.1002/ptr.5025; http://onlinelibrary.wiley.com/doi/10.1002/ptr.5025/abstract. eISSN: 1099-1573.
  177. Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. Lopresti, Adrian L., et al., et al. [ed.] Cornelius Katona and Hagop Akiskal. London; San Diego: Elsevier Inc., October 1, 2014, Journal of Affective Disorders, Vol. 167, pp. 368-375. DOI: 10.1016/j.jad.2014.06.001; http://www.jad-journal.com/article/S0165-0327(14)00362-0/abstract. ISSN: 0165-0327.
  178. Clinical Drug Information, LLC. Escitalopram. Drugs.com. [Online] April 1, 2015. [Cited: April 8, 2015.] .
  179. Cerner Multum, Inc. Venlafaxine. Drugs.com. [Online] August 23, 2014. [Cited: April 8, 2015.] http://www.drugs.com/venlafaxine.html.
  180. --. Fluoxetine. Drugs.com. [Online] August 26, 2014. [Cited: April 8, 2015.] http://www.drugs.com/fluoxetine.html.
  181. Scientific Opinion on the re-evaluation of curcumin (E 100) as a food additive. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). 9, Parma: European Food Safety Authority, September 10, 2010, EFSA Journal, Vol. 8, pp. 1679-1715. EFSA-Q-2008-220.
  182. National Toxicology Program. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1). U.S. Department of Health and Human Services. [Online] August 1993. [Cited: April 8, 2015.] http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr427.pdf. NTP TR 427; NIH Publication No. 93-3158.

Join the 1000s of People Who Are Discovering the Benefits of Turmeric.



New Vegan, Cruelty Free, Non GMO, Stearate Free, Gluten Free Turmeric Health Supplement Made in the USA in a GMP-certified, FDA-approved facility.

Healthceuticals® Turmeric Curcumin Complex

100% Certified
Organic ingredients

  • Organic Turmeric Extract - standardized to 95% curcuminoids.
  • Organic Whole Turmeric - provides full spectrum antioxidant, anti-inflammatory turmeric benefits, including turmerones and numerous vitamins, minerals, and phytonutrients
  • Organic Black Pepper Extract - standardized to 95% piperine; dramatically enhances bioavailablity.
  • Organic Phospholipids - markedly improve absorption.
  • Organic Ginger - works synergistically with turmeric to provide more powerful benefits.
  • Absolutely FREE of potentially harmful additives and fillers such as magnesium stearate.
Vegan | Cruelty Free | Non GMO | Stearate Free | Gluten Free Made in the USA in a GMP-certified, FDA-approved facility
Disclaimer: This website is not intended to replace professional consultation, diagnosis, or treatment by a licensed physician. If you require any medical related advice, contact your physician promptly. Information at this website is exclusively of a general reference nature. Do not disregard medical advice or delay treatment as a result of accessing information at this site.